| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1367-5931(02)00341-1 |
| P698 | PubMed publication ID | 12133719 |
| P50 | author | Heather A Carlson | Q57549493 |
| P2093 | author name string | Heather A Carlson | |
| P2860 | cites work | Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking | Q27631837 |
| Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach | Q28191975 | ||
| Chemogenomic approaches to drug discovery | Q28208482 | ||
| Developing a dynamic pharmacophore model for HIV-1 integrase. | Q30326870 | ||
| Analysis of a data set of paired uncomplexed protein structures: new metrics for side-chain flexibility and model evaluation. | Q30328086 | ||
| FlexE: efficient molecular docking considering protein structure variations. | Q30328164 | ||
| Industrial-scale, genomics-based drug design and discovery. | Q30328388 | ||
| High-throughput docking for lead generation | Q30663788 | ||
| Structure-based library design: molecular modelling merges with combinatorial chemistry | Q30873329 | ||
| Design, docking, and evaluation of multiple libraries against multiple targets | Q30978202 | ||
| Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations | Q31034789 | ||
| Docking ligands onto binding site representations derived from proteins built by homology modelling. | Q32181064 | ||
| Folding funnels and binding mechanisms | Q33743626 | ||
| Flexibility and packing in proteins | Q34008934 | ||
| Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles. | Q34503862 | ||
| Complexity and simplicity of ligand-macromolecule interactions: the energy landscape perspective | Q34604753 | ||
| Binding sites in Escherichia coli dihydrofolate reductase communicate by modulating the conformational ensemble | Q35367681 | ||
| Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule | Q43558049 | ||
| Protein flexibility predictions using graph theory | Q43629667 | ||
| Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock | Q43825573 | ||
| Contributions to the binding free energy of ligands to avidin and streptavidin. | Q43947466 | ||
| Binding mode prediction for a flexible ligand in a flexible pocket using multi-conformation simulated annealing pseudo crystallographic refinement | Q46347054 | ||
| Molecular docking to ensembles of protein structures | Q46668232 | ||
| Docking of small ligands to low-resolution and theoretically predicted receptor structures. | Q52043918 | ||
| Fully flexible low-mode docking: application to induced fit in HIV integrase. | Q52050278 | ||
| GRID/CPCA: a new computational tool to design selective ligands. | Q52074933 | ||
| Side-chain flexibility in proteins upon ligand binding. | Q52080522 | ||
| An analysis of conformational changes on protein-protein association: implications for predictive docking. | Q52215411 | ||
| Docking of flexible ligands to flexible receptors in solution by molecular dynamics simulation. | Q52216410 | ||
| Ligand docking to proteins with discrete side-chain flexibility. | Q52383197 | ||
| Parallel simulated tempering dynamics of ligand–protein binding with ensembles of protein conformations | Q57271320 | ||
| New roles for structure in biology and drug discovery | Q57881359 | ||
| Development of a New Type of Protease Inhibitors, Efficacious against FIV and HIV Variants | Q57976079 | ||
| A method for including protein flexibility in protein-ligand docking: improving tools for database mining and virtual screening | Q73047696 | ||
| Structural genomics programs at the US National Institute of General Medical Sciences | Q73263702 | ||
| Why are proteins marginally stable? | Q77360727 | ||
| P433 | issue | 4 | |
| P921 | main subject | protein design | Q410814 |
| P304 | page(s) | 447-452 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Current Opinion in Chemical Biology | Q15758415 |
| P1476 | title | Protein flexibility and drug design: how to hit a moving target | |
| P478 | volume | 6 |
| Q46639902 | (Thermo)dynamic role of receptor flexibility, entropy, and motional correlation in protein-ligand binding |
| Q92107770 | A comprehensive review of computational techniques for the prediction of drug side effects |
| Q41808100 | A computational study of the protein-ligand interactions in CDK2 inhibitors: using quantum mechanics/molecular mechanics interaction energy as a predictor of the biological activity. |
| Q45984545 | A docking study using atomistic conformers generated via elastic network model for cyclosporin A/cyclophilin A complex. |
| Q27902353 | A graph-based approach to construct target-focused libraries for virtual screening |
| Q42181291 | A quantum mechanic/molecular mechanic study of the wild-type and N155S mutant HIV-1 integrase complexed with diketo acid. |
| Q36282684 | Accelerated flexible protein-ligand docking using Hamiltonian replica exchange with a repulsive biasing potential |
| Q37409322 | An Evaluation of Explicit Receptor Flexibility in Molecular Docking Using Molecular Dynamics and Torsion Angle Molecular Dynamics |
| Q60951246 | An Improved Receptor-Based Pharmacophore Generation Algorithm Guided by Atomic Chemical Characteristics and Hybridization Types |
| Q34061377 | An allosteric modulator of HIV-1 protease shows equipotent inhibition of wild-type and drug-resistant proteases |
| Q36838120 | An improved relaxed complex scheme for receptor flexibility in computer-aided drug design |
| Q28740837 | Approximating protein flexibility through dynamic pharmacophore models: application to fatty acid amide hydrolase (FAAH) |
| Q33548098 | Assessing the structural conservation of protein pockets to study functional and allosteric sites: implications for drug discovery |
| Q30402973 | BUDDY-system: A web site for constructing a dataset of protein pairs between ligand-bound and unbound states |
| Q39411048 | Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets |
| Q30543685 | CSAR benchmark exercise 2011-2012: evaluation of results from docking and relative ranking of blinded congeneric series |
| Q41984039 | Calculations of binding affinity between C8-substituted GTP analogs and the bacterial cell-division protein FtsZ |
| Q37108161 | Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding |
| Q50595683 | Cation modulation of hemoglobin interaction with sodium n-dodecyl sulfate (SDS). II: calcium modulation at pH 5.0. |
| Q28292041 | Comparing neural-network scoring functions and the state of the art: applications to common library screening |
| Q26997089 | Computational methods in drug discovery |
| Q36633020 | Computational molecular modeling for evaluating the toxicity of environmental chemicals: prioritizing bioassay requirements |
| Q34519388 | Computer-aided drug-discovery techniques that account for receptor flexibility |
| Q40880715 | Conformational transition paths harbor structures useful for aiding drug discovery and understanding enzymatic mechanisms in protein kinases |
| Q34440071 | Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors |
| Q30938075 | Design and selection of ligands for affinity chromatography |
| Q34543371 | Design of growth factor sequestering biomaterials |
| Q36526030 | Designing ligands to bind proteins |
| Q33201132 | Development and testing of a de novo drug-design algorithm |
| Q36280727 | Discovery of Novel ROCK1 Inhibitors via Integrated Virtual Screening Strategy and Bioassays |
| Q36960711 | Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei |
| Q33635679 | Discovery of wild-type and Y181C mutant non-nucleoside HIV-1 reverse transcriptase inhibitors using virtual screening with multiple protein structures |
| Q45162110 | Docking and scoring of metallo-beta-lactamases inhibitors |
| Q41351067 | Druggability analysis and classification of protein tyrosine phosphatase active sites |
| Q47374327 | Dynamic Docking: A Paradigm Shift in Computational Drug Discovery |
| Q41020492 | Effect of Biomolecular Conformation on Docking Simulation: A Case Study on a Potent HIV-1 Protease Inhibitor. |
| Q36803981 | Effects of histidine protonation and rotameric states on virtual screening of M. tuberculosis RmlC. |
| Q44321337 | Efficient conformational sampling of local side-chain flexibility |
| Q35211087 | Efficient incorporation of protein flexibility and dynamics into molecular docking simulations |
| Q35218171 | Encompassing receptor flexibility in virtual screening using ensemble docking-based hybrid QSAR: discovery of novel phytochemicals for BACE1 inhibition. |
| Q48052175 | Energetics and structural characterization of the "DFG-flip" conformational transition of B-RAF kinase: a SITS molecular dynamics study |
| Q47750111 | Ensemble docking to difficult targets in early-stage drug discovery: Methodology and application to fibroblast growth factor 23. |
| Q30370020 | Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. |
| Q27001129 | Exploring the role of receptor flexibility in structure-based drug discovery |
| Q41508046 | Expression, Docking, and Molecular Dynamics of Endo-β-1,4-xylanase I Gene of Trichoderma virens in Pichia stipitis. |
| Q38754277 | Flexible CDOCKER: Development and application of a pseudo-explicit structure-based docking method within CHARMM |
| Q43153980 | Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking |
| Q28084584 | From protein structure to function via single crystal optical spectroscopy |
| Q56980133 | From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling |
| Q36985072 | Future directions for drug transporter modelling. |
| Q46318555 | How to pick a winning team: approaches towards the selection of computationally derived protein structures for ensemble-based virtual screening. |
| Q37459758 | Identification and validation of human DNA ligase inhibitors using computer-aided drug design |
| Q24656051 | Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach |
| Q35167908 | Implications of protein flexibility for drug discovery |
| Q36287460 | Implicit ligand theory: rigorous binding free energies and thermodynamic expectations from molecular docking. |
| Q41490277 | Importance of protein flexibility in ranking inhibitor affinities: modeling the binding mechanisms of piperidine carboxamides as Type I1/2 ALK inhibitors |
| Q30391029 | In Pursuit of Fully Flexible Protein-Ligand Docking: Modeling the Bilateral Mechanism of Binding |
| Q43170586 | In pursuit of virtual lead optimization: pruning ensembles of receptor structures for increased efficiency and accuracy during docking |
| Q40419101 | In pursuit of virtual lead optimization: the role of the receptor structure and ensembles in accurate docking |
| Q89314598 | In silico screening of isocitrate lyase for novel anti-buruli ulcer natural products originating from Africa |
| Q37036966 | Induced fit docking, and the use of QM/MM methods in docking |
| Q38330624 | Induced fit or conformational selection? The role of the semi-closed state in the maltose binding protein |
| Q92926402 | Initial Structural Models of the Aβ42 Dimer from Replica Exchange Molecular Dynamics Simulations |
| Q28539120 | Investigating the dynamic aspects of drug-protein recognition through a combination of MD and NMR analyses: implications for the development of protein-protein interaction inhibitors |
| Q57133493 | Large oxidation dependence observed in terahertz dielectric response for cytochrome c |
| Q57794695 | Ligand selection from the analysis of protein conformational substates: new leads targeting the N-terminal domain of Hsp90 |
| Q45125293 | Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4. |
| Q35929358 | Low potency toxins reveal dense interaction networks in metabolism |
| Q30352012 | MORPH-PRO: a novel algorithm and web server for protein morphing |
| Q40454703 | Mining protein dynamics from sets of crystal structures using "consensus structures". |
| Q51898453 | Modeling and selection of flexible proteins for structure-based drug design: backbone and side chain movements in p38 MAPK. |
| Q41886449 | Modulation of catalytic function by differential plasticity of the active site: case study of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase |
| Q93126855 | Molecular Docking: Shifting Paradigms in Drug Discovery |
| Q46427243 | Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors |
| Q38166531 | Molecular dynamics simulations of hsp90 with an eye to inhibitor design |
| Q46642485 | Molecular dynamics simulations of ligand-induced backbone conformational changes in the binding site of the periplasmic lysine-, arginine-, ornithine-binding protein. |
| Q35733861 | Molecular recognition in the case of flexible targets |
| Q30367220 | Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble. |
| Q36344445 | Novel method for probing the specificity binding profile of ligands: applications to HIV protease |
| Q36931811 | Overcoming the inadequacies or limitations of experimental structures as drug targets by using computational modeling tools and molecular dynamics simulations |
| Q38616659 | PeptiSite: a structural database of peptide binding sites in 4D. |
| Q35073109 | Predictive power of molecular dynamics receptor structures in virtual screening |
| Q24546265 | Probing a protein-protein interaction by in vitro evolution |
| Q79129188 | Probing the Kinetic Landscape of Transient Peptide−Protein Interactions by Use of Peptide 15N NMR Relaxation Dispersion Spectroscopy: Binding of an Antithrombin Peptide to Human Prothrombin |
| Q38428430 | Protein Flexibility in Drug Discovery: From Theory to Computation |
| Q38849439 | Protein conformational flexibility prediction using machine learning |
| Q37094819 | Protein dynamics and the immunological evolution of molecular recognition. |
| Q42081112 | Recipes for the selection of experimental protein conformations for virtual screening |
| Q35211103 | Significant enhancement of docking sensitivity using implicit ligand sampling |
| Q34091931 | Stabilization of anionic and neutral forms of a fluorophoric ligand at the active site of human carbonic anhydrase I |
| Q38379874 | Structure of ring-shaped Aβ₄₂ oligomers determined by conformational selection |
| Q58005447 | Structure-Based Methods for Predicting the Sites and Products of Metabolism |
| Q33238328 | Structure-based development of target-specific compound libraries |
| Q30419540 | Tackling the challenges posed by target flexibility in drug design |
| Q27643551 | The MUMO (minimal under-restraining minimal over-restraining) method for the determination of native state ensembles of proteins |
| Q45789568 | The assessment of computationally derived protein ensembles in protein-ligand docking. |
| Q38061633 | The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease |
| Q26801796 | Three-dimensional compound comparison methods and their application in drug discovery |
| Q37014096 | Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. |
| Q34092829 | Utilizing experimental data for reducing ensemble size in flexible-protein docking |
| Q33389195 | Virtual high throughput screening (vHTS)--a perspective |
| Q27656255 | ZINC--a free database of commercially available compounds for virtual screening |
Search more.